Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Daugaard

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 1, 1991
Cytokeratin intermediate filament pattern in uterine cervical biopsiesL N Nielsen, U Hørding, S Daugaard, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 1, 1993
Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysisJ Blaakaer, C K Høgdall, U Hørding, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 1, 1995
Imaging of chondrosarcoma with histopathological and prognostic correlation. An analysis of 49 cases mainly based on plain film radiographyA G Jurik, O Jensen, J Keller, et al.
Sarcoma|June 4, 2008
Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma GroupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
Sarcoma|January 1, 1997
Clinical and histopathological prognostic factors in chondrosarcomasS Daugaard, O Myhre-Jensen, T Schiødt, et al.
Gynecologic Oncology|November 1, 1991
Plasma tetranectin and ovarian neoplasmsC K Høgdall, E V Høgdall, U Hørding, et al.
Gynecologic and Obstetric Investigation|January 1, 1990
CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markersU Hørding, K Toftager-Larsen, A Dreisler, et al.
European Journal of Gynaecological Oncology|January 1, 1994
The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinomaU Hørding, K Toftager-Larsen, B Lund, et al.
Cancer|July 1, 1988
Prognostic factors in osteosarcomas. A regression analysisS M Bentzen, H S Poulsen, S Kaae, et al.
Gynecologic and Obstetric Investigation|January 1, 1992
CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinomaK Toftager-Larsen, U Hørding, A Dreisler, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 1, 1991
Cytokeratin intermediate filament pattern in uterine cervical biopsiesL N Nielsen, U Hørding, S Daugaard, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 1, 1993
Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysisJ Blaakaer, C K Høgdall, U Hørding, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 1, 1995
Imaging of chondrosarcoma with histopathological and prognostic correlation. An analysis of 49 cases mainly based on plain film radiographyA G Jurik, O Jensen, J Keller, et al.
Sarcoma|June 4, 2008
Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma GroupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
Sarcoma|January 1, 1997
Clinical and histopathological prognostic factors in chondrosarcomasS Daugaard, O Myhre-Jensen, T Schiødt, et al.
Gynecologic Oncology|November 1, 1991
Plasma tetranectin and ovarian neoplasmsC K Høgdall, E V Høgdall, U Hørding, et al.
Gynecologic and Obstetric Investigation|January 1, 1990
CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markersU Hørding, K Toftager-Larsen, A Dreisler, et al.
European Journal of Gynaecological Oncology|January 1, 1994
The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinomaU Hørding, K Toftager-Larsen, B Lund, et al.
Cancer|July 1, 1988
Prognostic factors in osteosarcomas. A regression analysisS M Bentzen, H S Poulsen, S Kaae, et al.
Gynecologic and Obstetric Investigation|January 1, 1992
CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinomaK Toftager-Larsen, U Hørding, A Dreisler, et al.
Pageof 6